Day procedures and higher-end outpatient care were flagged as key drivers, with the study also pointing to panel providers and group plans as potential cost moderators.
India's largest private sector general insurer's loss ratios in crop and fire lines increased during FY2026, however the business saw profits rise by over 10%.
Accelerating medical cost inflation, strained combined ratios, and rising protection gap demands urgent joint action from governments, regulators and insurers.
The development highlights ongoing regulatory efforts to address cost pressures and execution challenges in India’s rapidly growing private health insurance market.
The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
The budget outlines support for new insurance solvency rules and greater disclosure standards, but focus on growth sectors—such as low-altitude aviation and autonomous vehicles—will bring new opportunities...
The scheme shifts Religare’s lending, broking, and investment operations into Religare Finvest, with a separate listing targeted for Q1 FY28, subject to approvals.
